¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"l-"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • L-iduronidase
    L-¾ÆÀ̵ηδϵ¥À̽º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • L-DOPA
    L-µµÆÄ
  • L-form
    LÇü
  • L-type chnnels
    L-Çü Åë·Î(÷×ÖØ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • L-chain
    L»ç½½
  • L-configuration
    LÀÔüÇü»ó(Ø¡ô÷úþßÚ)
  • L-form
    LÇü(úþ)
  • L-L factor
    "L-L ÀÎÀÚ(ì×í­), (å²) Laki-Lorand ÀÎÀÚ(ì×í­)"
  • L-meromyosin
    L-¸Þ·Î¸¶ÀÌ¿À½Å
  • L-rRNA
    (ÑÀûÜ) RNA of the large ribosomal subunit
  • L-shaped structure
    L-Çü(úþ)±¸Á¶(ϰðã)
  • L-type structure
    L-Çü(úþ)±¸Á¶(ϰðã)
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
L-ASP L-asparaginase
L-BMAA L-beta-N-methylamino-L-alanine
L-cFA long chain fatty acid
L-D Leishman-Donovan [body]
L-DOPA, L-dopa levodopa, levo-3, 4-dihydroxyphenylalanine
l-hr lumen-hour
L-PAM L-Phenyl-Alanine Mustard
  = Melphalan
L-R left to right
L-S Letterer-Siwe [disease]
L-Spar asparaginase (Elspar)
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
L-2 line
L-4 lumbar
L-5-HTP L-5-hydroxytrypthophan
L-6 lumbar
L-929 line
L-AA L-Ascorbic acid
L-Ac L-Acetylcarnitine
L-AmB Liposomal amphotericin B
L-AP-4 L-amino-4-phosphonobutyric acid
L-AP3 L(+)-2-amino-3-phosphonopropionate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • L-dopa
    L-µµÆÄ
    levodo
  • L-form
    L-Çü
  • L-thyroxine
    L-ŸÀ̷νÅ, L-Ƽ·Ï½Å
    °©»ó¼±¿¡ ÀÇÇØ¼­ ºÐºñµÇ´Â °áÁ¤¼º ¿ä¿Àµå ÇÔÀ¯ È£¸£¸ó. ÁÖµÈ ±â´ÉÀº ´ë»çÀ²À» ÁõÁø½ÃŲ´Ù.
  • L-tryptophan
    L-Æ®¸³ÅäÆÇ
    ´Ü¹é¿¡ ÇÔÀ¯µÈ ¾Æ¹Ì³ë»ê. C8HN, CH2, CH, NH2COOH. ¿µ¾ÆÀÇ Àû´çÇÑ ¹ßÀ°, ¼ºÀÎÀÇ Áú¼Ò ´ë»çÀÇ ÆòÇü¿¡ ÇʼöÀûÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
L-2,3,4,5-tetrahydrodipicolinate succinyl coenzyme A succinyltransferase <enzyme> Catalyses conversion of l-2,3,4,5-tetrahydrodipicolinate to n-succinyl-2-amino-6-oxo-l-pimelate
Registry number: EC 2.3.1.-
Synonym: dapd gene product, thdpa-st
(26 Jun 1999)
L-2-hydroxyacid oxidase <enzyme> Consider also glycollate oxidase EC 1.1.3.1
Chemical name: oxidase, l-2-hydroxy acid
Registry number: EC 1.1.3.15
Synonym: l-alpha-hydroxy acid oxidase, lactate oxygen oxidoreductase
(26 Jun 1999)
L-3,4-dihydroxy-2-butanone-4-phosphate synthase <enzyme> Catalyses the conversion of d-ribulose 5-phosphate to l-3,4-dihydroxy-2-butanone-4-phosphate plus formate derived from carbon 4 of ribulose 5-p
Registry number: EC 5.4.-
Synonym: dbp synthase
(26 Jun 1999)
L-alpha-glycerol-phosphate oxidase <enzyme> Uses molecular oxygen; forms hydrogen peroxide and dehydroxyacetonephosphate
Registry number: EC 1.1.3.-
Synonym: glycerolphosphate oxidase
(26 Jun 1999)
l-alpha-narcotine <chemical> A naturally occurring opium alkaloid that is a centrally acting antitussive agent.
Pharmacological action: antitussive agents.
Chemical name: 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-
(12 Dec 1998)
L-aminoadipate saemialdehyde dehydrogenase <enzyme> Degrades saccharopine, enzyme defect in saccharopinuria
Registry number: EC 1.2.1.31
Synonym: alpha-aminoadipate reductase system, 2-aminoadipate reductase, aminoadipate-saemialdehyde dehydrogenase, alpha-aminoadipate reductase
(26 Jun 1999)
L-AP4 receptor A type of glutamate receptor that also binds a particular synthetic agonist and acts as a cation channel.
(05 Mar 2000)
L-arabino-aldose dehydrogenase <enzyme> Acts on sugars with l-arabino configuration at c2 through c4
Registry number: EC 1.1.1.-
(26 Jun 1999)
L-arabinose dehydrogenase <enzyme> See also record for EC 1.1.1.116, d-arabinose dehydrogenase
Registry number: EC 1.1.1.46
(26 Jun 1999)
L-ascorbate-2-sulfate sulfohydrolase <enzyme> Analyzed in arylsulfatase a
Registry number: EC 3.1.6.-
(26 Jun 1999)
L-aspartate oxidase <enzyme> E coli enzyme; forms unstable product, iminoaspartate; b protein of quinolinate synthetase
Registry number: EC 1.4.3.16
Synonym: b-protein, quinolinate synthetase, l-aspartate - fumarate oxidoreductase
(26 Jun 1999)
L-canaline reductase <enzyme> From leaves of canavalia ensiformis; mw 167 kD; catalyses a NADPH-dependent reductive cleavage of l-canaline to l-homoserine and ammonia
Registry number: EC 1.6.6.-
Synonym: NADPH-l-canaline oxidoreductase
(26 Jun 1999)
L-carbamoylase <enzyme> Hydrolyzes n-carbamoyl amino acids
Registry number: EC 3.5.1.-
Synonym: amab gene product
(26 Jun 1999)
l-carnitine <amino acid> Is a dipeptide - an amino acid made from two other aminos, methionine and lysine. It can be synthesised in the liver if sufficient amounts of lysine, B1, B6 and iron are available. Muscle and organ meat, fish and milk products are the best sources of carnitine in the diet.
Carnitine has been shown to have a major role in the metabolism of fat and in the reduction of triglycerides by increasing fat utilisation. It transfers fatty acids across the membranes of the mitochondria where they can be utilised as sources of energy. It also increases the rate at which the liver uses fats. By preventing fatty build-up, this amino acid aids in weight loss and decreases the risk of heart disease. Carnitine has been shown to be deficient in hearts of patients who have died of acute myocardial infections.
Muscular dystrophy and myotonic dystrophy have been shown to lead to carnitine loss in the urine and therefore higher requirements for it. Carnitine is stored primarily in the skeletal muscles and heart, where it is needed to transform fatty acids into energy for muscular activity. It is also concentrated in sperm and the brain. Many athletes have noted increased endurance and muscle building with carnitine supplementation.
Deficiencies may increase symptoms of fatigue, angina, muscle weakness or confusion. A low level of Vitamin C will also result in apparent Carnitine deficiency. It is contraindicated for people with liver or kidney disease or diabetes It has proven helpful in improving lipid metabolism and reducing elevated total lipids, cholesterol and triglycerides in people with cardiac problems and diabetes, but should only be taken with medical supervision in these conditions.
(25 Jun 1999)
L-chain disease bence Jones myeloma
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 1
  • L-Amino Acid Oxidase - »õâ An enzyme that catalyzes the oxidative deamination of L-amino acids to KETO ACIDS with the generation of AMMONIA and HYDROGEN PEROXIDE. L-amino acid oxidase is widely distributed in and is thought to contribute to the toxicity of SNAKE VENOMS.
    Synonyms : Apoxin I, Apoxin-I, L-Amino Acid-Oxygen Oxidoreductase (Deaminating), Ophio-Amino-Acid Oxidase, Acid Oxidase, L-Amino, L Amino Acid Oxidase, Ophio Amino Acid Oxidase, Oxidase, L-Amino Acid, Oxidase, Ophio-Amino-Acid
  • L-Aminoadipate-Semialdehyde Dehydrogenase - »õâ An enzyme that catalyzes the oxidation of L-2-aminoadipate 6-semialdehyde to L-2-aminoadipate (alpha-aminoadipic acid). It is involved in the biosynthetic pathway of LYSINE.
    Synonyms : 2-Aminoadipate Reductase, Aminoadipate-Semialdehyde Dehydrogenase, L-Aminoadipate Semialdehyde Dehydrogenase, alpha-Aminoadipate Reductase, alpha-Aminoadipate Reductase System, 2 Aminoadipate Reductase, Aminoadipate Semialdehyde Dehydrogenase
  • L-Gulonolactone Oxidase - »õâ An enzyme involved in the metabolism of ASCORBIC ACID and aldarate. It catalyzes the oxidation of L-gulono-1,4-lactone to L-xylo-hex-3-ulonolactone.
    Synonyms : L-Gulono-Gamma-Lactone Dehydrogenase, L-Gulono-Gamma-Lactone Oxidase, L-Gulonooxidase, Dehydrogenase, L-Gulono-Gamma-Lactone, L Gulono Gamma Lactone Dehydrogenase, L Gulono Gamma Lactone Oxidase, L Gulonolactone Oxidase, L Gulonooxidase
  • L-Iditol 2-Dehydrogenase - »õâ An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14
    Synonyms : Polyol Dehydrogenase, 2-Dehydrogenase, L-Iditol, Dehydrogenase, Iditol, Dehydrogenase, Polyol, Dehydrogenase, Sorbitol, L Iditol 2 Dehydrogenase
  • L-Lactate Dehydrogenase - »õâ A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist.
    Synonyms : Dehydrogenase, L-Lactate, Dehydrogenase, Lactate, L Lactate Dehydrogenase
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
³×Ǫ¼ÖÁÖ - »õâ
Á¾±Ù´ç
A01204721 L-histidine, L-leucine, L-lsoleucine, L-lysine acetate, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-valine
Àü¹®ÀǾàǰ | »èÁ¦
¸®ºê¶ôÁ¤¸ÆÁÖ»ç - »õâ
½ÅdzÁ¦¾à
A00301151 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
ÇìÆÄ¸áÁîÁÖ - »õâ
ÇÑÈ­Á¦¾à
A15300541 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿©
·¹º¸¸á½ºÁÖ500mg - »õâ
¸íÀÎÁ¦¾à
A09201921 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
¿À¸£ÆÄÁÖ - »õâ
µ¿±¤Á¦¾à
A01303931 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
ÇïźÀÎÇ»ÀüÁÖ - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12950491 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | »èÁ¦
ÇïÆ÷ºóÀÎÇ»ÀüÁÖ»ç¾× - »õâ
´ë¿øÁ¦¾à
A12802741 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿©
·¹º¸¸á½ºÁÖ»ç¾×5g - »õâ
¸íÀÎÁ¦¾à
A09201961 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
·¹¹ÙÅä´ÒÀÎÇ»Àü - »õâ
´ë¿ì¾àǰ°ø¾÷
A05402671 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
ÇìÆÄ¸áÁîÀÎÇ»ÀüÁÖ - »õâ
ÇÑÈ­Á¦¾à
A15300921 L-Ornithine-L-Aspartate
Àü¹®ÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
L-dopa the levorotatory form of dopa (trade names Bendopa and Brocadopa and Larodopa); as a drug it is used to treat Parkinson's disease
Ãâó: wordnet.princeton.edu/perl/webwn
L-amino-acid oxidase (L-ami
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
L-xylulose reductase (L-xy
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
L-deprenyl Selegiline (l-deprenyl, Eldepryl® or Anipryl® [veterinary]) is a drug used for the treatment of early-stage Parkinson's disease and senile dementia. In normal clinical doses it is a selective MAO-B inhibitor, however in very large doses (>25mg in a typical adult) it loses its specificity and also inhibits MAO-A. Since it is selective for MAO-B, no special dietary restrictions are needed as with other MAOI drugs. ...
Ãâó: en.wikipedia.org/wiki/L-deprenyl
L-phase variant L-forms are bacterial spheroplasts or protoplasts originating from normal bacteria following partial (spheroplasts) or complete (protoplasts) removal of the cell wall. The formation of L-forms can be either spontaneous (occurring during certain phase of growth) or artificial (suppression of the rigid cell wall by stimuli such as enzymes, heat-shock, or special L-form induction medium, etc. ...
Ãâó: www.hardydiagnostics.com/Glossary-L.html
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
l- the levorotatory form of dopa (trade names Bendopa and Brocadopa and Larodopa)
l- a long-playing phonograph record
l- (British) a square plate bearing the letter L that is attached to both ends of a car to indicate that the driver is a learner
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á